LOGO
LOGO

quick facts

  • Novo Nordisk's Wegovy Pill Wins CHMP Recommendation For Approval In EU May 22, 2026 11:57 ET

    Friday, Novo Nordisk A/S (NVO) announced that the Committee for Medicinal Products for Human Use under the European Medicines Agency has recommended marketing authorisation of Wegovy pill to reduce excess body weight and maintain long-term weight reduction. The recommendation is backed by findings...

  • AstraZeneca, Daiichi Sankyo's Datroway Gets Approval In US For Treatment Of Breast Cancer May 22, 2026 10:35 ET

    Friday, AstraZeneca PLC (AZN) along with Daiichi Sankyo (DSKYF.PK) announced that Datroway has been approved in the U.S. for the treatment of adult patients with unresectable or metastatic triple negative breast cancer. The approval comes after Priority Review by the U.S. Food and Drug Administration...

  • Assembly Biosciences Prices 3.35 Mln Shares At $26.50/shr; To Expand ABI-6250 Development; Stock Up May 22, 2026 08:42 ET

    Assembly Biosciences, Inc (ASMB), a biotechnology company, on Friday announced that it has priced underwritten offering of 3.35 million shares of common stock at an offering price per share of common stock of $26.50, to raise around $100 million in gross proceeds. Separately, the company announced...

  • AbbVie's MAVIRET Secures Positive CHMP Opinion For Acute Hepatitis C Infection Treatment May 22, 2026 08:38 ET

    Friday, AbbVie Inc. (ABBV) announced that the European Medicines Agency's Committee for Medicinal Products for Human Use has adopted a positive opinion recommending the approval of MAVIRET for the treatment of acute hepatitis C infection in adults and children aged 3 years and older. If approved,...

  • Merck Reports Positive CHMP Recommendation For KEYTRUDA Plus Padcev May 22, 2026 08:27 ET

    Merck (MRK) announced the European Medicines Agency's Committee for Medicinal Products for Human Use adopted a positive opinion recommending approval of KEYTRUDA, Merck's anti-PD-1 therapy, in combination with Padcev, an antibody-drug conjugate, as neoadjuvant treatment and then continued after radical...

  • Gilead Gets Positive CHMP Opinion For Trodelvy In First-Line Metastatic TNBC May 22, 2026 08:25 ET

    Gilead Sciences Inc. (GILD) on Friday said the European Medicines Agency's Committee for Medicinal Products for Human Use recommended marketing authorization for Trodelvy as a first-line treatment for adults with unresectable locally advanced or metastatic triple-negative breast cancer. A decision...

  • Regeneron Pharmaceuticals's Genetic Hearing Loss Drug Wins EMA Filing Acceptance May 22, 2026 08:10 ET

    Friday, Regeneron Pharmaceuticals, Inc. (REGN) announced that Otarmeni has been accepted by European Medicines Agency for review under Accelerated Assessment the Marketing Authorization Application for the treatment of biallelic OTOF variant-associated hearing loss. The application is backed by data...

  • BJ's Wholesale Club Q1 Earnings Slip; Confirms FY26 Guidance May 22, 2026 07:15 ET

    BJ's Wholesale Club Holdings, Inc. (BJ), a regional membership-only warehouse club chain, on Friday reported lower net income in the first quarter of fiscal 2026 despite higher sales and revenue compared with the previous year, while maintaining its full-year 2026 guidance. For the first quarter,...

  • So-Young Posts Wider Loss In Q1; Total Revenues Up 45.6% May 22, 2026 05:33 ET

    So-Young International (SY) reported a first quarter net loss attributable to So-Young of RMB 49.2 million compared with a net loss of RMB 33.1 million, a year ago. Loss per ADS was RMB 0.48 compared with a loss per ADS of RMB 0.32. Non-GAAP net loss attributable to So-Young was RMB 46.6 million, compared...

  • Eiffage To Build Four Solar Plants For Morocco's NOOR Atlas Project; Backs FY26 Outlook May 22, 2026 04:02 ET

    Eiffage SA (FGR.PA, EFGSF), on Friday through its subsidiary Eiffage Énergie Systèmes, is building four solar power plants in Morocco for the NOOR Atlas programme on behalf of the Moroccan Agency for Sustainable Energy or MASEN. The construction began in early 2026 and delivery is scheduled for mid-2027. The...

  • Generali Q1 Adj. Net Result Rises May 22, 2026 03:21 ET

    Generali (GE1G, GDEUF.PK) reported first quarter net result of 1.17 billion euros compared to 1.19 billion euros, prior year. Operating result was 2.2 billion euros, up 8.1%. Adjusted net result rose by 5.2% to 1.27 billion euros. Adjusted EPS was 0.84 euros, compared to 0.79 euros. Without one-off tax...

  • Quantum Computing Stocks Rally After U.S. Announces $2 Billion Funding Plan May 22, 2026 03:16 ET

    Shares of quantum computing companies surged Thursday and extended gains in after-hours trading after the U.S. government said it would provide about $2 billion in federal incentives to nine companies to accelerate domestic quantum computing research and manufacturing. The Department of Commerce said...

  • Frontline Q1 Earnings Jump May 22, 2026 02:37 ET

    Frontline Plc (FRO, FRO.OL), a shipping company, on Friday reported higher net income in the first quarter of 2026 compared with the previous year, driven by a strong tanker market amid Middle East disruptions. For the first quarter, profit increased to 559.12 billion from 33.29 billion in the previous...

  • Richemont FY26 Net Profit Climbs, Profit From Cont. Opns Down; Lifts Dividend May 22, 2026 02:25 ET

    Compagnie Financiere Richemont AG (CFRUY, CFRHF), a Swiss luxury goods company, reported Friday higher net profit in fiscal 2026, while profit from continuing operations declined from last year, despite sales growth. The firm further announced higher dividend. In fiscal 2026, profit attributable to...

  • FortuneX Acquisition Announces Pricing Of 7.50 Mln Units IPO At $10.00/unit May 22, 2026 01:56 ET

    FortuneX Acquisition Corp. (FXACU) Friday announced the pricing of its Initial Public Offering or IPO of 7.5 million units at $10.00 per unit. Each unit consists of one ordinary share and one-half of one redeemable warrant, with each whole warrant exercisable to purchase one ordinary share at $11.50...

Global Economics Weekly Update -May 18 – May 22, 2026

May 22, 2026 14:46 ET
Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.

Latest Updates on COVID-19